Upstream and Downstream Manufacturing in the Biopharmaceutical Industry In-house Training

In this talk, explore the fundamental concepts, techniques, and processes that make up the backbone of biomanufacturing, pharmaceutical production, and biotechnology. More details...

Tailored to your team's requirements, at your choice of location or online.


From

£200

Per delegate, based on 10 delegates and a duration of 2 days


Contact our in-house team

Part of Molecule to Medicine series:

Are you seeking an understanding of the steps that turn scientific innovations into therapeutic products? This exciting series provides a concise overview of the drug development process, from early-stage research through to the creation of medicines. Participants will learn about key topics such as molecule discovery, preclinical testing, clinical trials, and the regulatory processes involved in bringing a medicine to market.

Overview

Bioprocessing is the use of biological systems (such as cells, enzymes, or microorganisms) to produce valuable products, like pharmaceuticals, biofuels, or specialty chemicals. This process is typically broken down into two main stages: upstream processing and downstream processing. Both play vital roles in ensuring the efficient production, purification, and quality control of the final product.

Upstream processing encompasses everything that occurs before the actual production of the product, and it’s primarily concerned with creating an optimal environment for microorganisms or cell cultures to grow and produce the target product.

Once the biological system has generated the product in upstream processing, the focus shifts to downstream processing, which involves purification and formulation to ensure the product is safe, pure, and suitable for commercial use.

Upstream and downstream processes are interconnected. The choice of cell culture methods, fermentation conditions, and media formulation can significantly affect the yield and purity of the product, which in turn impacts the complexity and cost of downstream processing.

This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.

Benefits of attending

Attending this session will not only deepen your knowledge but also equip you with the practical tools and strategies needed to enhance both upstream and downstream manufacturing processes, improve product quality, and navigate the complexities of the biopharmaceutical industry. The benefits of attending this session include:

  • Learn about the latest industry trends, technologies, and strategies being employed to improve upstream and downstream processes. This can help you adopt cutting-edge practices to enhance operational efficiency and reduce production costs
  • Understand key challenges and innovative solutions related to process optimisation, scale-up, and product consistency across both upstream and downstream stages. Knowledge in this area can help reduce bottlenecks and improve yield
  • See best practices in maintaining product quality, with a focus on techniques like process validation, quality assurance, and regulatory compliance to ensure the safety and effectiveness of biologics
  • Engage with experts, researchers, and other professionals in the biopharmaceutical field
  • Gain insights into the regulatory requirements for both upstream and downstream biopharmaceutical manufacturing processes. This can help ensure compliance with FDA, EMA, and other regulatory bodies, minimising the risk of delays or regulatory hurdles
  • Explore the latest technological advancements in biomanufacturing, such as automation, artificial intelligence, and continuous manufacturing processes, and how these can be integrated into both upstream and downstream operations to improve efficiency and scalability
  • Discuss the factors that contribute to cost reduction in the production process, such as the selection of cost-effective raw materials, automation, and process optimisation techniques. This knowledge can help drive profitability without compromising product quality
  • Delve into upstream and downstream processes and see how they fit into the larger context of the product life cycle, from discovery through clinical trials to commercial production

 

Who should attend?

  • Bioprocess engineers
  • Process development scientists
  • Quality Assurance (QA) and Quality Control (QC) professionals
  • Manufacturing supervisors and operators
  • Regulatory affairs managers
  • R&D (Research and Development) team members
  • Project managers in biotechnology/pharmaceuticals
  • Supply chain and logistics teams
  • Senior leadership (e.g., CTOs, VPs of Operations)
  • External consultants and contractors
  • Finance and costing analysts
  • Students and trainees in biotechnology and pharmaceutical sciences
  • Environmental Health and Safety (EHS) personnel
  • Automation and IT specialists

France

  • Boehringer Ingelheim Animal Health France

Switzerland

  • Roche

Run Upstream and Downstream Manufacturing in the Biopharmaceutical Industry Bespoke training for your team

90-minutes

Typical duration

Pricing from:

  • GBP 200
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our team to discuss your requirements:

You may also be interested in... See more

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Harry Altamont

Harry
ALTAMONT

Aleksandra Beer

Aleksandra
BEER

+44 (0)20 7749 4749

inhouse@ipiacademy.com